Focus DX

Cypress, United States Founded: 1978 • Age: 48 yrs Acquired By DiaSorin
Diagnostic assays and reagents for infectious diseases are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Focus DX

Focus DX is a company based in Cypress (United States) founded in 1978 was acquired by DiaSorin in March 2016. Focus DX operates in a competitive market with competitors including DermTech, Inflammatix, Karius, MeMed and Visby Medical, among others.

  • Headquarter Cypress, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Focus Diagnostics, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    DiaSorin

    (Mar 29, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Focus DX

Premium access

Detailed funding history for Focus DX

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Focus DX

Focus DX has secured backing from 1 investor. Prominent investors backing the company include DiaSorin.

All
Investor Description Founded Year Domain Location
Reagent kits for in vitro diagnostics are developed and commercialized.
Locked Locked Locked
Premium access

Investor details for Focus DX

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Focus DX

Investments
Premium access

Investment portfolio details for Focus DX

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Focus DX

Premium access

Detailed financials for Focus DX

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Focus Dx Comparisons

Focus DX Primary company
Description
Diagnostic assays and reagents for infectious diseases are d...
Location
Cypress, United States
Founded Year
1978
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Focus DX

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Focus DX

Focus DX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, Inflammatix, Karius, MeMed and Visby Medical, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Adhesive patch biopsies for skin cancer detection are provided.
Locked Locked Locked
Provider of diagnostic solutions for systemic infections
Locked Locked Locked
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
Locked Locked Locked
Provider of machine learning based diagnostic solutions for infectious diseases
Locked Locked Locked
Portable PCR diagnostics for infectious diseases are developed.
Locked Locked Locked
Developer of a platform for low cost molecular testing
Premium access

Detailed competitors of Focus DX

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Focus Dx

Premium access

Complete news archive for Focus DX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Focus DX

Focus DX was founded in 1978.

Focus DX is headquartered in Cypress, United States. It is registered at Cypress, California, United States.

Focus Diagnostics was founded in 1978 and is based in Cypress, United States. Diagnostic assays and reagents for infectious diseases are developed by the company within the healthcare sector. The flagship Integrated Cycler serves as a benchtop real-time PCR instrument compatible with proprietary Simplexa Molecular assays. Solutions for diagnosing respiratory infections, sexually transmitted diseases, vector-borne diseases, and hospital-associated infections are provided.

Focus DX's top competitors include Visby Medical, Inflammatix and DermTech.

Focus DX has 1 investor. Key investors include DiaSorin.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available